MoneyWorks4Me

Aarti Pharmalabs informs about press release

07 Feb 2025 Evaluate
Aarti Pharmalabs has informed that the extract of Standalone and Consolidated Audited Financial Results for the quarter ended December 31, 2024, have been published in the following newspapers: Financial Express (English) on Friday, February 07, 2025; Loksatta -Jansatta (Gujarati) on Friday, February 07, 2025. A copy of the Newspaper publications is enclosed.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

867.75 0.00 (0.00%)
03-Sep-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.00
Dr. Reddys Labs. 1160.05
Cipla 1407.50
Lupin 2170.00
Zydus Lifesciences 1151.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: